Correlation Between Oryzon Genomics and Arteche Lantegi

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oryzon Genomics and Arteche Lantegi at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oryzon Genomics and Arteche Lantegi into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oryzon Genomics SA and Arteche Lantegi Elkartea, you can compare the effects of market volatilities on Oryzon Genomics and Arteche Lantegi and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oryzon Genomics with a short position of Arteche Lantegi. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oryzon Genomics and Arteche Lantegi.

Diversification Opportunities for Oryzon Genomics and Arteche Lantegi

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Oryzon and Arteche is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Oryzon Genomics SA and Arteche Lantegi Elkartea in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arteche Lantegi Elkartea and Oryzon Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oryzon Genomics SA are associated (or correlated) with Arteche Lantegi. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arteche Lantegi Elkartea has no effect on the direction of Oryzon Genomics i.e., Oryzon Genomics and Arteche Lantegi go up and down completely randomly.

Pair Corralation between Oryzon Genomics and Arteche Lantegi

Assuming the 90 days trading horizon Oryzon Genomics SA is expected to generate 2.54 times more return on investment than Arteche Lantegi. However, Oryzon Genomics is 2.54 times more volatile than Arteche Lantegi Elkartea. It trades about 0.23 of its potential returns per unit of risk. Arteche Lantegi Elkartea is currently generating about 0.04 per unit of risk. If you would invest  143.00  in Oryzon Genomics SA on December 30, 2024 and sell it today you would earn a total of  183.00  from holding Oryzon Genomics SA or generate 127.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Oryzon Genomics SA  vs.  Arteche Lantegi Elkartea

 Performance 
       Timeline  
Oryzon Genomics SA 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Oryzon Genomics SA are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Oryzon Genomics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Arteche Lantegi Elkartea 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Arteche Lantegi Elkartea are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Arteche Lantegi is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Oryzon Genomics and Arteche Lantegi Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oryzon Genomics and Arteche Lantegi

The main advantage of trading using opposite Oryzon Genomics and Arteche Lantegi positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oryzon Genomics position performs unexpectedly, Arteche Lantegi can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arteche Lantegi will offset losses from the drop in Arteche Lantegi's long position.
The idea behind Oryzon Genomics SA and Arteche Lantegi Elkartea pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stocks Directory
Find actively traded stocks across global markets